Author year [ref] | VRE | Study ID | Design | Country | Year of study | Subject description | Screening site | Screening method | Latest documented follow up (weeks) | N | Lost to follow up (N) | Clearance defined | Weeks to documented clearance | % cleared |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Montecalvo 1995 [27] | VREF | A | Prospective cohort | USA | 1993-4 | Hospitalized patients | Perianal | CX; T | 18 | 86 | 50 | 1 negative CX on admission and weekly negative culture during admission | 18 | 2% |
Brennen 1998 [28] | VREF | B | Prospective cohort | USA | 1993-4 | Residents in LTCFs | Rectal | CX | 25 | 36 | * | 2 negative CX on 2 separate samplings | 10 | 50%†|
Goetz 1998 [29] | VREF | C | Prospective cohort | USA | 1994-6 | Hospitalized patients | Rectal or stool | CX | * | 210 | 61 | 1 negative CX on 2 separate samplings | 14 | 40%†|
Bhorade 1999 [30] | ND | D | Prospective cohort | USA | 1996-8 | Hospitalized patients | Rectal or stool | CX | 2 | 10 | 6 | 1 negative CX on 5 separate samplings | N/A | 0% |
Weinstein 1999 [31] | VREF | E | Prospective cohort | Canada | 1995 | Hospitalized patients | Rectal | CX | 25 | 24 | 0 | 1 negative CX on at least 3 separate samplings | 25 | 38% |
D’Agata 2001 [32] | ND | F | Prospective cohort | USA | 1998 | Hospitalized patients | Rectal | CX | 3 | 13 | 6 | 1 negative culture on at least 2 separate samplings | 1 | 8% |
Wong 2001 [33] | ND | G | RCT | USA | * | Hospitalized patients and residents of LTCFs | Rectal | CX | 3 | 24 | 4 | 1 negative CX on 3 separate samplings | 3 | 21% |
Byers 2002 [34] | ND | H | Retrospective cohort | USA | 1994-6 | Hospitalized patients | Rectal | CX; T | 86 | 116 | 0 | 1 negative CX on 3 separate samplings | 22 | 64% |
Hachem and Raad 2002 [35] | VREF | I | Prospective cohort | USA | 1997 | Hospitalized patients | Stool | CX | 13 | 28 | 0 | 1 negative CX on at least 2 separate samplings | 13 | 4% |
Mascini 2003 [36] | VREF | J | Prospective cohort | Netherlands | 2000 | Hospitalized patients | Rectal | CX; PCR;T | 26 | 11 (a) | * | 3 negative CX on at least 3 separate samplings | 6 | 50%†|
Huang 2007 [37] | ND | K1 | Retrospective cohort | USA | 2002-4 | Hospitalized patients | Rectal | CX; PCR (b) | 52 | 394 (c) | * | 1 negative CX | 9 | 24% |
Huang 2007 [37] | ND | K | Retrospective cohort | USA | 2002-4 | Hospitalized patients | Rectal | CX; PCR (b) | 52 | 126 (d) | * | 1 negative CX | 43 | 84% |
Park 2011 [38] | ND | L1 | Retrospective cohort | South Korea | 2003-10 | Hospitalized patients on chronic HD | Rectal | CX | 39 | 89 | 20 | 1 negative CX on 3 separate samplings | 16 | 10% |
Park 2011 [38] | ND | L | Retrospective cohort | South Korea | 2003-10 | Hospitalized patients on non-chronic HD | Rectal | CX | 35 | 723 | 339 | 1 negative CX on 3 separate samplings | 9 | 12% |
Yoon 2011 [39] | VREF | M | Retrospective cohort | South Korea | 2006-9 | Hospitalized patients | Rectal | CX | 19 | 58 | * | 1 negative CX on 3 separate samplings | 19 | 28% |